Bioventus Inc.
BVS | undefined
$13.45
+$0.07 (+0.52%)
Sep 22, 2026, 9:35 AM ET · Market open
Market Data
Market Cap $901.73M
Enterprise Value $1.14B
Beta 0.65
Average Volume 697.41K
Shares Outstanding (Diluted) 70.84M
Shares Change YoY 3.36%
Institutional Ownership 75.87%
Exchange NASDAQ
ISIN US09075A1088
Price Performance
Price Change 1M -8.0%
Price Change 3M 43.3%
Price Change 6M 45.3%
Price Change YTD 84.6%
Price Change 1Y 91.8%
Price Change 3Y 354.3%
Price Change 5Y -9.2%
1M CAGR (ann.) -5.8%
1Y CAGR (ann.) 84.9%
5Y CAGR (ann.) -1.6%
All-Time CAGR -6.3%
Valuation
PE Ratio 17.29
Forward PE 14.22
PEG Ratio 0.00
Forward PEG 0.91
PS Ratio 1.55
Forward PS 1.40
PB Ratio 3.95
P/FCF Ratio 8.78
P/Adj. FCF Ratio 10.68
P/OCF Ratio 9.31
EV/Sales 1.95
EV/EBIT 19.41
EV/EBITDA 12.24
EV/FCF 11.07
Earnings Yield 5.8%
FCF Yield 11.4%
Adj. FCF Yield 9.4%
Financial Health
Net Debt $219M
Total Debt $263.75M
Cash & Short-Term Investments $29.46M
Total Assets $673.35M
Current Ratio 1.69
Quick Ratio 1.17
Debt / Equity Ratio 1.16
Debt / EBITDA 2.84
Debt / FCF 2.57
OCF / Debt 0.40
Interest Coverage 3.11
Altman Z-Score 2.08
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 68.0%
Operating Profit Margin 10.6%
EBITDA Margin 15.9%
Net Profit Margin 9.4%
FCF Margin 17.6%
Adj. FCF Margin 14.5%
SBC / Revenue 2.6%
SBC Impact (per share) -17.7%
Returns
Return on Assets 8.1%
Return on Equity 28.4%
Return on Invested Capital 11.4%
Return on Capital Employed 11.9%
Return on Tangible Assets 17.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 4.5%
Revenue CAGR 5Y 9.1%
Revenue CAGR 10Y 8.4%
EPS CAGR 3Y 2204.1%
EPS CAGR 5Y 1.4%
EPS CAGR 10Y -19.7%
FCF CAGR 3Y 135.9%
FCF CAGR 5Y 34.5%
FCF CAGR 10Y 13.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y 10.9%
Revenue Growth Next 3Y 8.3%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $0.17
EPS Growth Est (next Q) 13.3%
Revenue Est (next Q) $149.51M
Revenue Growth Est (next Q) 7.8%
Fair Value Estimates
Graham Number $8.42
Graham Upside -36.7%
Lynch Fair Value $3.85
Lynch Upside -71.1%
Price Target $18.33
Price Target Upside 37.7%
Cash Flow
Operating Cash Flow $105.81M
Free Cash Flow $102.65M
Adj. Free Cash Flow $84.46M
FCF Per Share $1.39
OCF Per Share $1.43
OCF/S Ratio 16.6%
Income Statement
Revenue $581.85M
Gross Profit $395.64M
Operating Income $61.83M
EBITDA $92.82M
Net Income $54.46M
EPS (Diluted) $0.77
Revenue / Employee $612.47K
Profit / Employee $57.33K
Employees 950
Add to Watchlist
Select watchlists to add or remove BVS